Polypeptide Conjugate Preparation via Selective Precipitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing physiologically active polypeptide conjugates face challenges such as low stability, frequent administration requirements due to peptide degradation, and inefficient preparation yields, particularly due to non-specific binding of polymers to active domains, which reduces peptide activity and increases preparation complexity.
Innovation Solution
A two-step method involving selective precipitation to separate unconjugated physiologically active polypeptides from non-peptidyl polymers, followed by site-specific conjugation using organic solvents like isopropanol, to achieve high yields and purity of the polypeptide conjugates, and subsequent conjugation with physiologically active carriers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a non-peptidyl polymer is chemically added to the surface of the peptide to increase stability and prevent degradation, then the stability and potency of the peptide drug are improved, but the preparation yield is reduced due to non-specific binding of the polymer to the peptide
Solution Approach 1:
The patent applies local quality by modifying only specific amino acid residues (such as lysine or N-terminal amino groups) of the peptide with the non-peptidyl polymer, rather than random non-specific binding. This site-specific conjugation maintains the peptide's active domains while improving stability, and the controlled local modification enhances preparation yield by preventing non-specific polymer-peptide interactions.
Solution Approach 2:
The patent employs preliminary action by pre-modifying the non-peptidyl polymer with specific functional groups (such as aldehyde, carboxyl, or activated ester groups) before conjugation to the peptide. This pre-functionalization allows for controlled and specific binding to predetermined sites on the peptide, preventing non-specific binding and improving both stability and preparation yield.
2Reliability
If site-specific binding is used to prevent non-specific binding and maintain peptide activity, then the activity of the peptide is preserved, but the preparation yield is reduced or artificial manipulation is required
Solution Approach 1:
The patent applies parameter changes by optimizing the pH, temperature, and molar ratio of reactants during the conjugation process. By carefully controlling these parameters, the reaction favors site-specific binding while minimizing non-specific interactions, thereby maintaining peptide activity and improving preparation yield without requiring artificial manipulation.
Solution Approach 2:
The patent uses an intermediary approach by introducing a spacer arm or linker molecule between the non-peptidyl polymer and the peptide. This intermediary allows the polymer to bind to the peptide at a specific site while maintaining the peptide's active conformation, thus preserving activity and improving yield by preventing non-specific binding.
3Reliability
If frequent administration of peptide drugs is performed to maintain blood levels, then the potency of the drug is maintained, but severe pain is caused to patients
Solution Approach 1:
The patent creates a composite material by covalently linking the non-peptidyl polymer to the peptide drug. This polymer-peptide conjugate combines the pharmacological activity of the peptide with the extended circulation time and reduced immunogenicity of the polymer, resulting in prolonged blood levels and reduced dosing frequency, thereby eliminating the need for frequent painful injections.
Solution Approach 2:
The patent applies partial action by using a sub-stoichiometric amount of non-peptidyl polymer relative to the peptide, creating a conjugate with extended half-life that maintains therapeutic blood levels for longer periods. This reduces the dosing frequency and associated patient pain while maintaining adequate drug potency.
4Productivity
If a two-step reaction with selective precipitation is performed to improve preparation yield, then the yield and purity of the conjugate are increased, but the process complexity is increased
Solution Approach 1:
The patent applies the extraction principle by using selective precipitation to separate the desired polymer-peptide conjugate from unreacted peptide and other impurities in the reaction mixture. This simple extraction step, based on differential solubility, effectively increases preparation yield and purity without requiring complex chromatographic or centrifugation procedures.
Solution Approach 2:
The patent employs phase transitions by controlling the solubility of the conjugate and unreacted peptide through changes in solvent composition, temperature, or pH. By inducing selective precipitation (a phase separation), the desired conjugate is isolated in high yield and purity through a simple filtration step, avoiding complex purification processes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enhances the yield and stability of physiologically active polypeptide conjugates, allowing for long-acting formulations with prolonged in vivo activity and increased blood half-life, reducing the need for frequent administration and maintaining high pharmacological efficacy.
Implementation Method 1
a physiologically active polypeptide and a non-peptidyl polymer are linked to each other via a covalent bond
Implementation Method 2
the unreacted (unconjugated) physiologically active polypeptide is separated by selective precipitation
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Provided is a method of preparing a physiologically active polypeptide conjugate, in which a physiologically active polypeptide and a non-peptidyl polymer are linked to each other via a covalent bond. The method is to improve an overall yield of the physiologically active polypeptide conjugate by improving a reaction of the non-peptidyl polymer and the physiologically active polypeptide, and particularly, the method is to prepare a physiologically active polypeptide conjugate in a high yield by performing a two-step reaction through selective precipitation. The preparation method of the present invention is used to produce a non-peptidyl polymer-physiologically active polypeptide conjugate and a physiologically active polypeptide-physiologically active carrier conjugate in a high yield, and therefore, the method may be used in the development of long-acting formulations of various peptide drugs which maintain in vivo activity at a relatively high level and have remarkably increased blood half-life.